Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Khani F, Robinson BD. Precursor Lesions of Urologic Malignancies. Arch Pathol Lab Med. 2017;141(12):1615-1632.

Greenblatt MB, Tsai JN, Wein MN. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin Chem. 2017;63(2):464-474.

DiBardino DM, Rawson DW, Saqi A, Heymann JJ, Pagan CA, Bulman WA. Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology. Cytojournal. 2017;14:7.

Goel R, Snow J, Pri-Paz SM, Cushing M, Vasovic LV. Intrauterine transfusions for severe fetal anemia and hydrops due to de novo εγδβ-thalassemia. Transfusion. 2017;57(4):876.

McHugh D, Caduff N, Barros MH, Rämer PC, Raykova A, Murer A, et al. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression. Cell Host Microbe. 2017;22(1):61-73.e7.

Marchionni L, Netto GJ, Hoque MO, Argani P. MicroRNAs, promising biomarkers in the diagnosis of Xp11 translocation RCC-reply. Hum Pathol. 2017;68:206-207.

Yang GC, Fried KO, Scognamiglio T. Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma: A Review of 179 Cases. Diagn Cytopathol. 2017;45(6):533-541.

Dinerman BF, Khani F, Golan R, Bernstein AN, Cosiano MF, Margolis DJ, et al. Population-based study of the incidence and survival for intraductal carcinoma of the prostate. Urol Oncol. 2017;35(12):673.e9-673.e14.

Blattner M, Liu D, Robinson BD, Huang D, Poliakov A, Gao D, et al. SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. Cancer Cell. 2017;31(3):436-451.

Calvert AE, Chalastanis A, Wu Y, Hurley LA, Kouri FM, Bi Y, et al. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation. Cell Rep. 2017;19(9):1858-1873.